Cadila recalls its drug in the US

Cadila Healthcare recalls 15,144 bottles of its hypertension drug in the US


The company is recalling the drug due to discoloration

Cadila Healthcare has decided to recall its 15,144 bottles of its anti-hypertension drug, Amlodipine Besylate tablets in the US market.

As per reports, Zydus Pharmaceuticals USA, the US-based arm of the company, is recalling the drug due to "discoloration".

The withdrawal is classified as a Class-III which FDA defined as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email